Please login to the form below

Not currently logged in
Email:
Password:

Pfizer UK

This page shows the latest Pfizer UK news and features for those working in and with pharma, biotech and healthcare.

Pfizer/BioNTech's COVID-19 vaccine found to be effective against UK virus variant

Pfizer/BioNTech's COVID-19 vaccine found to be effective against UK virus variant

UK. The study – published on the preprint server bioRxiv – used the blood of 16 participants in Pfizer/BioNTech’s previously reported phase 1/2 trial of BNT162b2 to test for neutralisation ... The study was conducted using blood samples from 20

Latest news

More from news
Approximately 2 fully matching, plus 145 partially matching documents found.

Latest Intelligence

  • Boosting innovation in healthcare and scientific communications Boosting innovation in healthcare and scientific communications

    communications. She spent the last decade working as a director of communications for Pfizer, Inc., in New York, the UK and Paris.

  • The trials and tribulations of rare opportunities The trials and tribulations of rare opportunities

    Jack Brownrigg, Medical Affairs, Rare Disease, Pfizer UK, told us clinical trials with fewer potential participants required more nuanced trial designs. ... Patient-centricity is also core to Pfizer’s rare disease recruitment strategy, said Brownrigg.

  • The Orkambi blame game The Orkambi blame game

    The hearing was more or less unprecedented in terms of a pharma company’s CEO being called on to explain its tactics before UK Parliament – the questioning of Pfizer’s ... These included questions to Jeff Leiden about his salary, the company’s

  • In conversation with Pfizer’s Erik Nordkamp In conversation with Pfizer’s Erik Nordkamp

    Pfizer’s UK managing director and newly appointed ABPI President talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe. ... 10.8% of GDP is spent on healthcare in the Netherlands versus 9.8% in the UK.

  • Happy 70th birthday NHS: the next 70 need to be very different Happy 70th birthday NHS: the next 70 need to be very different

    Erik Nordkamp, Managing Director of Pfizer UK and the new ABPI President elect (pictured), struck a very different tone, congratulating the NHS and pledging to work closely with the health service. ... care spending in the UK has fallen by 9.9% between

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

  • Roudie Shafie joins OVID Health’s senior team as director Roudie Shafie joins OVID Health’s senior team as director

    Shafie's previous experience includes roles at the ABPI and Pfizer UK. ... Shafie’s career experience includes time spent as head of government affairs at the ABPI and corporate public affairs lead for Pfizer UK.

  • Pfizer’s Alan Maine moves to Edelman Pfizer’s Alan Maine moves to Edelman

    Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... Prior to his time with Pfizer, Maine was

  • Makara Health appoints Louise Finke as a director Makara Health appoints Louise Finke as a director

    director. Finke brings 15 years industry experience from the likes of Shire and Wyeth (now part of Pfizer) to the Southampton, UK-based agency, having previously worked on market access challenges

  • Cytovation expands management team Cytovation expands management team

    Airey (pictured right) becomes venture developer at the biotech, bringing 28 years of healthcare operating experience at firms including Baxter and Pfizer across the UK, Europe and India.

  • ABPI names Amgen’s UK head as president ABPI names Amgen’s UK head as president

    He replaces Jonathan Emms, who is stepping down as president as he is leaving his role as head of Pfizer's UK business to a new role with the company in ... Kearney held UK and international roles at GlaxoSmithKline and international roles at Pfizer,

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • Wilmington Healthcare appoints new Head of Digital

    Wilmington Healthcare, which provides data, insight and intelligence for pharma and medtech companies, has appointed Pfizer’s former UK Digital Marketing Manager, Mikko Figura, as Head of Digital. ... Prior to that, he was UK Digital Marketing Manager

  • Mistrust in medical research: a patient perspective

    Health Products Regulatory Agency’s speedy  approval of the Pfizer-BioNTech COVID-19 vaccine in the UK. ... A good example is a recent incident in the UK that made headline news, where two NHS workers who were among the first to receive the

  • New recommendations to stimulate braver and bolder communications

    Cannes or Canned? brought together UK and internationally based senior communicators from seven pharmaceutical companies. ... Lilianna Husseini, Director Communications, Oncology, Pfizer Global. Heidi LaPensée, Brand Lead, CNS, Sanofi UK.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Patient recruitment and retention 2021 state of play
At COUCH Health, we’ve recently done some social listening to look into the discussions around ‘patient recruitment’ and ‘patient retention’, to see if these conversations have been impacted by the...
The UK has approved the first vaccine for COVID-19. What now?
The authorisation of Pfizer/BioNtech's mRNA vaccine by the MHRA is great news, but no-one has ever tried to roll out a vaccine as rapidly as this one, so we have...
Clinical trials and the diversity principle
If they were ever really hidden, 2020 revealed the expensive-sounding problems limiting diversity in clinical trials. Solutions are overdue....

Infographics